文献速递消化道肿瘤与早癌消化内镜

30至49岁人群使用粪便免疫化学检测进行结直肠癌筛查:聚焦筛查起始年龄

Colorectal cancer screening with the fecal immunochemical test in persons aged 30 to 49 years: focusing on the age for commencing screening.
PubMed 文献 · Gastrointest Endosc · 2017-04-03

本研究回顾性分析了接受结肠镜和粪便免疫化学检测(FIT)的健康筛查参与者,比较30-49岁各年龄亚组FIT阳性者与50-59岁平均风险对照组的进展期结直肠肿瘤(ACRN)检出比例。结果显示35-49岁FIT阳性者的ACRN比例高于50-59岁平均风险人群,而30-34岁组无显著差异,提示FIT筛查可能从35岁开始。

要点

  • 35-49岁FIT阳性者的进展期结直肠肿瘤风险高于50-59岁平均风险人群。
  • 30-34岁FIT阳性者的进展期结直肠肿瘤比例与50-59岁平均风险人群无显著差异。
  • FIT阳性者35-49岁可能从筛查结肠镜获益,支持从35岁开始FIT筛查的可能性。

核心结论

  • 35-49岁FIT阳性者相比50-59岁平均风险个体具有更高的进展期结直肠肿瘤风险。
  • 35-49岁FIT阳性者可能从筛查结肠镜获益,从而支持从35岁开始FIT筛查的可能性。

研究设计与样本

  • 回顾性分析接受结肠镜和FIT的健康筛查项目参与者记录。
  • 将30-49岁参与者分为30-34、35-39、40-44、45-49岁4个亚组,以50-59岁平均风险参与者为对照组。
  • 共分析19808名30-49岁参与者和2233名50-59岁平均风险参与者的数据。

主要发现

  • 50-59岁平均风险参与者的进展期结直肠肿瘤(ACRN)患病率为3.8%。
  • FIT阳性参与者中,30-34、35-39、40-44、45-49岁组的ACRN比例分别为2.9%(95%CI 1.1%-7.4%)、9.7%(95%CI 5.8%-15.6%)、7.7%(95%CI 4.5%-12.8%)、14.6%(95%CI 8.7%-23.5%)。
  • 35-39、40-44、45-49岁FIT阳性组的ACRN比例高于50-59岁平均风险组(P分别为.001、.014、<.001)。
  • 30-34岁FIT阳性组的ACRN比例与50-59岁平均风险组无显著差异(P=.566)。

临床怎么用

  • 原文结论认为35-49岁FIT阳性者可能从筛查结肠镜获益,支持从35岁开始FIT筛查的可能性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The fecal immunochemical test (FIT) can be an alternative screening method for colorectal cancer in individuals aged <50 years. However, debate continues concerning the age at which commencing FIT is beneficial. METHODS: We reviewed the records of participants who had undergone a colonoscopy and FIT as part of a comprehensive health screening program. To determine the age for commencing screening via FIT, participants aged <50 years were classified into 4 age subgroups as follows: 30 to 34, 35 to 39, 40 to 44, and 45 to 49 years. Average-risk participants aged 50 to 59 years comprised the control group. RESULTS: We analyzed the data of 19,808 participants aged 30 to 49 years and 2233 average-risk participants aged 50 to 59 years. The advanced colorectal neoplasia (ACRN) prevalence in average-risk participants aged 50 to 59 years was 3.8%. In the subgroups of FIT-positive participants, the proportion of participants with ACRN was 2.9% (95% confidence interval [CI], 1.1%-7.4%), 9.7% (95% CI, 5.8%-15.6%), 7.7% (95% CI, 4.5%-12.8%), and 14.6% (95% CI, 8.7%-23.5%) in groups 30 to 34, 35 to 39, 40 to 44, and 45 to 49 years, respectively. The proportion of FIT-positive participants with ACRN in the groups aged 35 to 39, 40 to 44, and 45 to 49 years was higher than that in average-risk participants aged 50 to 59 years (P = .001, P = .014, and P < .001, respectively), whereas that in FIT-positive participants aged 30 to 34 years was not (P = .566). CONCLUSION: FIT-positive individuals aged 35 to 49 years had a higher risk of ACRN compared with average-risk individuals aged 50 to 59 years. FIT-positive individuals aged 35 to 49 years may benefit from screening colonoscopy, thus justifying the possibility of commencing FIT from age 35 years.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Jung YS, Park CH, Kim NH, et al. Colorectal cancer screening with the fecal immunochemical test in persons aged 30 to 49 years: focusing on the age for commencing screening. Gastrointest Endosc. 2017. PMID: 28385585. doi:10.1016/j.gie.2017.03.1531

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。